Patents by Inventor Eric Kool
Eric Kool has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250054581Abstract: Data encodable polymers, including nucleic polymers, for data storage and related methods are described. Generally, a nucleic acid polymer can have chemically modifiable structures iteratively repeated along the polymer. The chemically modifiable structures can be modified to encode data. A data encoding device can have a spatial resolution that modifies a string of contiguous chemically modifiable structures to yield a cluster of modified structures. Various methods can be utilized to generate a data encodable nucleic acid polymer. Various methods can be utilized to encode a data encodable nucleic acid polymer. Various methods of decoding can be utilized to decode an encoded nucleic acid or other polymer.Type: ApplicationFiled: August 20, 2024Publication date: February 13, 2025Inventor: Eric Kool
-
Publication number: 20250022543Abstract: Nucleic acid polymers for data storage and related methods are provided. In some embodiments, the nucleic acid polymers are writable for data, and in other embodiments, the nucleic acid polymers are encoded with data when synthesized. Generally, a writable polymer may contain one or more convertible residues (e.g., chemically alterable group) bits that are enabled to provide a data code. Various methods can be utilized to generate a writable nucleic acid polymer, or a data encoded nucleic acid polymer. Various methods can be utilized to encode a nucleic acid polymer by selectively modifying convertible residues via a light or redox source with an enzyme (e.g., polymerase) conjugated to a sensitizer. Various methods of reading an encoded nucleic acid polymer are also described herein.Type: ApplicationFiled: March 21, 2024Publication date: January 16, 2025Inventor: Eric Kool
-
Publication number: 20240427528Abstract: Provided herein are writable polymers (e.g., writable nucleic acid polymers) for data storage and related methods. Generally, a writable polymer (e.g., a nucleic acid polymer) contains one or more convertible residues (e.g., convertible nucleobases) that are capable of being converted from a first state to a second state, the first and the second state being different. Various methods can be utilized to generate a writable nucleic polymer, such as polymerase extension via rolling circle reaction or chemical synthesis and ligation. Also provided herein are various methods for writing or encoding a writable nucleic acid polymer by selectively converting nucleobases into the second state. Also provided herein are various methods for reading or decoding a nucleic acid polymer encoded with data.Type: ApplicationFiled: January 11, 2024Publication date: December 26, 2024Inventor: Eric Kool
-
Publication number: 20240391946Abstract: Described herein are writable polymers for data storage and related methods. Generally, a writable polymer may contain one or more convertible residues (e.g., convertible residues comprising a modifiable fluorophore with switchable fluorescent states) that are enabled to provide a data code. Various methods can be utilized to generate a writable polymer (e.g., a writable nucleic polymer). Various methods can be utilized to encode a writable polymer by selectively modifying the one or more convertible residues (e.g., modifiable fluorophores). Various methods of reading a polymer encoded with data are also described herein.Type: ApplicationFiled: January 11, 2024Publication date: November 28, 2024Inventor: Eric Kool
-
Publication number: 20230235395Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: ApplicationFiled: March 31, 2023Publication date: July 27, 2023Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Patent number: 11643684Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: GrantFiled: November 6, 2020Date of Patent: May 9, 2023Assignee: Illumina, Inc.Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Publication number: 20210164040Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: ApplicationFiled: November 6, 2020Publication date: June 3, 2021Applicant: Illumina, Inc.Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Patent number: 10837056Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: GrantFiled: March 13, 2019Date of Patent: November 17, 2020Assignee: Illumina, Inc.Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Publication number: 20190376136Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: ApplicationFiled: March 13, 2019Publication date: December 12, 2019Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Patent number: 10233493Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: GrantFiled: December 22, 2017Date of Patent: March 19, 2019Assignee: Illumina, Inc.Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Publication number: 20180155783Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: ApplicationFiled: December 22, 2017Publication date: June 7, 2018Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Patent number: 9862998Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: GrantFiled: April 19, 2016Date of Patent: January 9, 2018Assignee: ILLUMINA, INC.Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Publication number: 20160298186Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: ApplicationFiled: April 19, 2016Publication date: October 13, 2016Applicant: Illumina, Inc.Inventors: MOLLY HE, CHENG-YAO CHEN, ERIC KOOL, MOSTAFA RONAGHI, MICHAEL PREVITE, RIGO PANTOJA
-
Patent number: 9353412Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: GrantFiled: June 16, 2011Date of Patent: May 31, 2016Assignee: Illumina, Inc.Inventors: Molly He, Cheng-Yao Chen, Eric Kool, Mostafa Ronaghi, Michael Previte, Rigo Pantoja
-
Publication number: 20110312529Abstract: This disclosure provides a method of determining a sequence of nucleotides for a nucleic acid template. The method can include the steps of contacting the nucleic acid template with a conformationally labeled polymerase and at least four different nucleotide species under conditions wherein the conformationally labeled polymerase catalyzes sequential addition of the nucleotide species to form a nucleic acid complement of the nucleic acid template, wherein the sequential addition of each different nucleotide species produces a conformational signal change from the conformationally labeled polymerase and wherein the rate or time duration for the conformational signal change is distinguishable for each different nucleotide species; detecting a series of changes in the signal from the conformationally labeled polymerase under the conditions; and determining the rates or time durations for the changes in the signal, thereby determining the sequence of nucleotides for the nucleic acid template.Type: ApplicationFiled: June 16, 2011Publication date: December 22, 2011Applicant: ILLUMINA, INC.Inventors: MOLLY HE, CHENG-YAO CHEN, ERIC KOOL, MOSTAFA RONAGHI, MICHAEL PREVITE, RIGO PANTOJA
-
Publication number: 20070233853Abstract: User connection information can be displayed. User connection information can represent user connections to a plurality of computer servers of a multi-server system. User connection information can be received from a plurality of computer servers, user details can be obtained, and a representation of the user connection information for the plurality of computer servers can be displayed. Users connected to computer servers can be notified by displaying a representation of user connection information, displaying a user-notification task, receiving a selection of the user notification task, and notifying the users of an event. User connection information can be retrieved and displayed by retrieving user connection information from a plurality computer servers of a multi-server system, storing the retrieved user connection information, and displaying a representation of the user connection information based on the stored user connection information.Type: ApplicationFiled: March 30, 2006Publication date: October 4, 2007Applicant: Microsoft CorporationInventors: Kanchuki Sarma, Mai-Ian Bukovec, Eric Watson, Ryan Elliott, Eric Kool-Brown
-
Publication number: 20070065360Abstract: Nonpolar thymidine analogs are provided comprising a dihalogenated or trihalogenated base of the structure: where R1 is a sugar moiety; R2 is H or CH3; an imaging moiety or a cytotoxic moiety and X1 and X2 are independently selected from I, Cl, Br, and F, with the proviso that not more than one F will be present at these positions.Type: ApplicationFiled: September 11, 2006Publication date: March 22, 2007Inventor: Eric Kool
-
Publication number: 20060199192Abstract: A universal linker structure is provided, in which a functional group and activating leaving group are placed on a tether, allowing the placement of an electrophile at the end of any nucleic acid sequence. The electrophile on the tether can react with a second nucleic acid carrying a nucleophile when the two nucleic acids are hybridized near one another, resulting in release of the leaving group, and creation of a functional change. The linker can be designed to destabilize the ligation product without slowing the rate of reaction. This lowers product inhibition, and the target DNA or RNA can become a catalyst for isothermally generating multiple signals for detection. This enhanced signal is demonstrated in solution experiments and in solid supported assays. The universal linkers of the present invention are simple and inexpensive to prepare, and can be appended to any polynucleotide in automated steps on a standard DNA synthesizer.Type: ApplicationFiled: September 1, 2005Publication date: September 7, 2006Inventors: Eric Kool, Hiroshi Abe
-
Publication number: 20060160125Abstract: The invention is directed to novel compositions and methods for nonenzymatic ligation of oligonucleotides. In one aspect of the invention, the nonenzymatic ligation is selenium-mediated or tellurium mediated ligation. In another aspect, the invention provides for the use of fluorescence resonance energy transfer (FRET) to detect the nonenzymatic ligation.Type: ApplicationFiled: March 10, 2006Publication date: July 20, 2006Applicant: University of RochesterInventor: Eric Kool
-
Publication number: 20060154889Abstract: Nucleoside analogs comprising polyfluorinated benzene, pyrrole, pyridine, indole, isoindole, or benzoimidazole rings are shown to provide for selective base pairing with self, or other polyfluorinated analogs, in preference to native nucleic acid bases. The analogs of the invention stabilize the stacking of helices, and increase hydrophobicity when introduced into an oligonucleotide.Type: ApplicationFiled: December 5, 2005Publication date: July 13, 2006Inventor: Eric Kool